FreeStyle LibreLink App (with LibreView)

by Abbott  · Based in United States → — Real-time glucose readings, sent right to your patients' smartphones.
Endocrinology Family Medicine Internal Medicine
Website
Claim this tool
Is this the maker? Claim the company →

Free
Regulatory Status Disclosed

Overview

The FreeStyle LibreLink App, developed by Abbott, allows patients to monitor their glucose levels directly from a compatible smartphone using a FreeStyle Libre sensor. It provides real-time glucose readings, an 8-hour glucose history, and directional arrows indicating glucose trends. The app also generates in-app reports that visualize trends and patterns, helping patients understand their glucose control. When paired with LibreView, a secure, cloud-based diabetes management system, patients can automatically share their glucose data with healthcare professionals. This enables physicians to remotely review, analyze, and evaluate historical glucose data, facilitating informed treatment decisions and more productive patient conversations. LibreView offers customizable, intuitive reports, including a summary of glucose, sensor usage, carbohydrate, insulin, and quantitative hypoglycemic data over a 14-day period, as well as an Ambulatory Glucose Profile (AGP).

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Real-time glucose readings on smartphone
  • 8-hour glucose history
  • Glucose trend arrows
  • In-app reports for glucose patterns and trends
  • Automatic data upload to LibreView
  • Optional glucose alarms (with FreeStyle Libre 2 and 3 sensors)
  • Customizable reports for healthcare professionals
  • Remote patient monitoring
  • Time In Range graphs
  • Daily Patterns graphs

Use Cases

  • Continuous glucose monitoring for diabetes management
  • Remote monitoring of patient glucose data by healthcare professionals
  • Facilitating informed treatment decisions based on historical glucose data
  • Identifying glucose patterns and trends for therapy adjustments
  • Enhancing patient-provider communication regarding diabetes management
  • Supporting care coordination among healthcare teams

What Physicians Need to Know

Key Capabilities
The FreeStyle LibreLink app allows patients to monitor glucose levels from their smartphone by scanning a FreeStyle Libre sensor. It displays current glucose readings, trend arrows, and up to 8 hours of glucose history. Patients can add notes for food, insulin use, and exercise. The app generates various glucose reports, including the Ambulatory Glucose Profile (AGP), daily patterns, time in target range, low glucose events, average glucose, and an estimated HbA1c. It also offers customizable reminders and, with the FreeStyle Libre 2 system, real-time glucose alarms.
Clinical Utility
The FreeStyle LibreLink app, in conjunction with LibreView, provides healthcare professionals with access to consistent, clear, and intuitive glucose reports, enabling easier and faster identification of patterns and trends. This supports informed treatment decisions, optimization of treatment plans through remote patient monitoring, and better coordination of care among care team members. The reports can be customized, printed, or saved, and include summaries of glucose, sensor usage, carbohydrate, insulin, and hypoglycemic data.
Integration Options
The FreeStyle LibreLink app automatically uploads glucose data to LibreView, a secure cloud-based diabetes management system, when the phone has an internet connection. Healthcare professionals can access patient data through their LibreView account. Patients can also share their glucose data with up to 20 family and friends via the LibreLinkUp app. The FreeStyle Libre system and its digital health tools are integrated into platforms like Omada Health's digital coaching platform. The FreeStyle Libre 2 and 3 sensors are also authorized for use with various automated insulin delivery systems and smart insulin pens.
Compliance Status
The FreeStyle LibreLink app is FDA approved for compatible iPhones. LibreView is ISO27001/27018/27701 certified and HITRUST CSF Certified, and it meets or exceeds HIPAA requirements, complying with state and federal regulations for data security and privacy.
Pricing Model
The FreeStyle LibreLink app is free to download. LibreView is also free to set up and use for both patients and healthcare professionals.
User Experience
The app offers a convenient way to monitor glucose on the go with a painless one-second phone scan. It provides real-time glucose readings and allows for easy viewing of glucose history and trends. The reports in the app are noted to have more color, details, and interactivity compared to the FreeStyle Libre reader. However, some users have reported issues with data loss if the sensor expires before scanning, and occasional inaccuracies in readings. There have also been comments about the app's user-friendliness and the need for improved features like zooming in on graphs.
Support Quality
Abbott Diabetes Care provides customer support for the FreeStyle LibreLink app. Some users have reported unsatisfactory experiences with customer care regarding app issues and sensor malfunctions.
Implementation Complexity
Setting up the FreeStyle LibreLink app requires a compatible smartphone and registration with LibreView. Connecting to a healthcare professional's LibreView practice can be done by entering a Practice ID or accepting an email invitation. While the app itself is relatively straightforward, using both the app and a FreeStyle Libre reader with the same sensor requires starting the sensor with the reader first.
Evidence Base
The FreeStyle Libre and FreeStyle Libre 14 Day Flash Glucose Monitoring systems are continuous glucose monitoring (CGM) devices indicated for replacing blood glucose testing and detecting trends and patterns to aid in the detection of hyperglycemia and hypoglycemia, facilitating therapy adjustments in persons with diabetes. LibreView is intended to assist in the review, analysis, and evaluation of historical glucose data to support effective diabetes management.
Physician Tip

Encourage patients to consistently scan their FreeStyle Libre sensor with the LibreLink app and ensure internet connectivity for automatic data upload to LibreView. This provides a comprehensive glucose profile for more informed clinical decisions. Utilize the customizable reports in LibreView to identify glucose patterns, trends, and areas for intervention, such as time in range, daily patterns, and hypoglycemic events. Educate patients on the importance of fingerstick blood glucose tests when symptoms do not match sensor readings or when readings are suspected to be inaccurate. Leverage the remote monitoring capabilities of LibreView to track patient progress between visits and optimize treatment plans.

The FreeStyle LibreLink app seamlessly integrates with LibreView for secure, cloud-based data storage and sharing with healthcare professionals. It also connects with the LibreLinkUp app, allowing patients to share glucose data with family and friends. Additionally, the FreeStyle Libre system has integrations with various third-party digital health platforms and automated insulin delivery systems, expanding its utility in a connected care ecosystem.

Details

Category Endocrinology & Metabolic AI, Wearables & Remote Monitoring (RPM)
Pricing Free
DeploymentCloud-based
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Endocrinology, Family Medicine, Internal Medicine

What the Web Says

The FreeStyle LibreLink app, used with LibreView, allows individuals with diabetes to monitor their glucose levels via a smartphone, eliminating the need for a separate reader. It provides real-time data, trend analysis, and the ability to share information with healthcare professionals. Real-world data suggests that users of the app spend more time in their target glucose range compared to those using a dedicated reader.

Overall: Mixed

Strengths

  • Simplifies glucose monitoring by using a smartphone instead of a separate reader.
  • Provides real-time, actionable glucose data directly to smartphones.
  • Users experience more time in the target glucose range, lower glucose variability, and less hyperglycemia.
  • Facilitates data sharing with healthcare professionals for remote monitoring and improved diabetes management through LibreView.
  • Allows users to add notes for tracking food, insulin use, and exercise.
  • Offers glucose reports, including Ambulatory Glucose Profile.

Limitations

  • Some users report issues with sensor accuracy and functionality, including sensors not scanning or providing incorrect readings.
  • Customer support can be difficult to reach or unhelpful for some users.
  • If the sensor is not scanned before it expires, the data is lost.
  • Charts within the app may lack detailed functionality, such as zooming in or viewing individual minute-by-minute values.
  • The app and dedicated FreeStyle Libre Readers do not share data with each other directly.
  • Fingersticks are still required for treatment decisions in certain situations, such as when symptoms don't match readings or when readings are suspected to be inaccurate.

Based on reviews from: Abbott (Journal of Diabetes Science and Technology), FreeStyle Libre Website, Google Play Store (FreeStyle LibreLink reviews), Reddit (r/Freestylelibre)

Last updated: 2026-09-23

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate FreeStyle LibreLink App (with LibreView)

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

The Hindu
Abbott launches FreeStyle LibreLink app to measure glucose level without pricking
Abbott launched its FreeStyle LibreLink app in India, allowing users to measure glucose levels via smartphone without finger pricking, utilizing NFC technology to transfer data from the sensor to the app. The app enables real-time glucose tracking, historical data review, and sharing with healthcare providers through LibreView and LibreLinkUp.
2023-11
JDC monthly diabetes newsletter
Apps linked with FreeStyle Libre: LibreLink, LibreLinkUp & LibreView | JDC monthly diabetes newsletter. Issue 180 October, 2023
The FreeStyle LibreLink app allows individuals with diabetes to monitor glucose using a smartphone and sensor, offering 8-hour glucose history, trend patterns, and in-app reports like Daily Patterns and Time in Range. LibreView is a secure, cloud-based system for healthcare professionals and patients to review comprehensive reports from compatible FreeStyle devices.
2023-10
Therapeutic Goods Administration (TGA)
FreeStyle LibreLink Android App | Therapeutic Goods Administration (TGA)
Abbott Australasia Pty Ltd addressed issues with the FreeStyle LibreLink app on Android 13 OS, where users experienced signal loss and missed glucose alarms. A software update (version 2.8.4) was released to fix this problem, and users were advised to update their app.
2023-02
Abbott Newsroom (via Journal of Diabetes Science and Technology)
Real-World Data Show Abbott's FreeStyle LibreLink App Users Spend More Time in Target Glucose Range Compared to Reader Users
New real-world data published in the Journal of Diabetes Science and Technology indicates that FreeStyle LibreLink app users spend an average of 5% more time in their target glucose range compared to those using a traditional reader. The study also showed lower glucose variability, lower average glucose, and less hyperglycemia for app users, highlighting the benefits of mobile apps and telehealth for remote glucose monitoring.
2021-09
The Diabetes Times
FreeStyle LibreLink app users spend more time in 'target glucose range' compared to traditional reader users, new data shows
Research shows that people with diabetes using the FreeStyle LibreLink app spend 5% more time in their target glucose range than those using a traditional reader. This improvement is attributed to the app's data sharing features, which facilitate informed treatment decisions by healthcare professionals and caregivers.
2021-09
PR Newswire
Abbott Receives Health Canada Authorization under Interim Order to Use FreeStyleu00ae Libre System for Hospitalized Patients During COVID-19 Pandemic
Health Canada authorized the use of Abbott's FreeStyle Libre system for hospitalized patients during the COVID-19 pandemic, allowing remote glucose monitoring via LibreView. The FreeStyle LibreLink app, compatible with the system, enables healthcare workers to monitor patients' glucose status and history, minimizing contact and PPE use.
2020-04
PR Newswire
Abbott and Omada Health Partner to Offer Integrated Digital Health and Coaching Experience for People with Type 2 Diabetes
Abbott partnered with Omada Health to provide an integrated digital health and coaching experience for individuals with Type 2 diabetes. The FreeStyle LibreLink app allows users to view real-time glucose levels and history on their smartphone, with data securely shared through LibreView to healthcare professionals and Omada coaches for personalized recommendations.
2019-10
Abbott Newsroom
FreeStyle LibreLink App FDA Approved | Abbott Newsroom
The FreeStyle LibreLink app received FDA approval for use with compatible iPhones in the U.S., allowing users to monitor glucose levels directly on their smartphones. This digital health tool integrates real-time glucose data, 8-hour history, and trend patterns, eliminating the need for a separate reader.
2018-11

Videos

Product demos, reviews, and walkthroughs for FreeStyle LibreLink App (with LibreView).

View all on YouTube

Frequently Asked Questions

The FreeStyle LibreLink app and LibreView utilize AI for pattern recognition in glucose data, identifying trends and potential hypoglycemic or hyperglycemic events. This helps physicians quickly assess patient adherence and make data-driven adjustments to treatment plans. The AI primarily focuses on data visualization and trend analysis rather than autonomous decision-making.
Abbott states that the FreeStyle LibreLink app and LibreView are designed with patient data privacy and security in mind, adhering to relevant healthcare regulations like HIPAA and GDPR. Data is encrypted both in transit and at rest, and access is restricted to authorized users. AI processing occurs within this secure environment, with anonymized or de-identified data used for broader trend analysis where appropriate.
The AI in the FreeStyle LibreLink app and LibreView is primarily a data analysis and visualization tool, not a diagnostic or prescriptive AI. It may not fully account for complex patient variables, such as acute illness, medication changes, or significant lifestyle shifts, which can influence glucose readings. Clinical judgment remains paramount, and the AI should be used as a supportive tool rather than a replacement for comprehensive medical evaluation.
Yes, several other CGM systems offer varying degrees of AI-powered insights, such as Dexcom G6 and G7, and Guardian Connect. These systems also provide trend analysis, predictive alerts, and integration with data platforms for physician review. The 'best' alternative often depends on specific patient needs, integration with existing EHRs, and the level of AI-driven insights desired by the physician.
The FreeStyle LibreLink app and LibreView are generally free for patients to download and use, as their primary function is to display data from the FreeStyle Libre sensors. The cost to patients primarily comes from the purchase of the disposable FreeStyle Libre sensors. For healthcare providers, access to LibreView for patient management is also typically free. There are no additional hidden costs specifically associated with the AI features, as they are integrated into the existing platform.
The FreeStyle LibreLink app and LibreView aim to improve patient compliance and engagement by providing real-time glucose data and easy-to-understand trends, empowering patients to better manage their diabetes. The AI contributes by highlighting patterns and potential issues, which can motivate patients to make timely adjustments to their diet or activity. The user-friendly interface and data sharing capabilities also encourage consistent use and communication with healthcare providers.

Related Tools

SureMediks ProView
SureMediks (Rasimo Systems, LLC)
Clinical Decision Support & Reference
SureMediks is an AI-powered clinical decision support and metabolic health platform that automates care workflows for specialists, providing AI-generated patient summaries, automated chart review, and real-time biometric alerts.
SigXA
SigXA
Documentation & Scribing
SigXA is an AI medical scribe and ambient assistant that transforms patient encounters into structured clinical documentation, specifically tuned for endocrinology teams to manage hormonal and metabolic conditions with protocol-driven longitudinal monitoring.
Paid, free trial
Nirmitee.io Diabetes Care Intelligence
Nirmitee.io
Endocrinology & Metabolic AI
Nirmitee.io Diabetes Care Intelligence is an AI-powered platform that integrates CGM data, analyzes 14-day CGM patterns, and correlates them with insulin doses, meal timing, and activity to generate specific dosing recommendations for personalized diabetes management.
Wellma for Practitioners
Wellma
Clinical Decision Support & Reference
Wellma for Practitioners is an AI co-pilot that extends care plans between sessions, providing real-time client insights, structured follow-up, and pre-session briefs for metabolic health conditions.
Virta Health
Virta Health
Endocrinology & Metabolic AI
Virta Health offers a virtual health program focused on reversing Type 2 diabetes, prediabetes, and obesity through a nutrition-first approach, continuous remote care, and personalized coaching.
Hybrid
PNOĒ
PNOĒ
Endocrinology & Metabolic AI
PNOĒ is a science-backed cardiometabolic analyzer that performs comprehensive breath-based assessments to measure 23 biomarkers, including VO₂ max, resting metabolic rate (RMR), fat burn efficiency, and biological age. It delivers a 360° snapshot of an individual's physiology by analyzing how oxygen flows through the lungs, heart, and cells. The insights generated are used to personalize nutrition, exercise, and longevity plans.
Varies

See all Endocrinology & Metabolic AI tools →

More from Abbott

Abbott LibreView for Healthcare Professionals
Abbott
Endocrinology & Metabolic AI
Abbott LibreView for Healthcare Professionals is a secure, cloud-based diabetes management system that allows healthcare professionals to view, analyze, and share glucose data from Abbott FreeStyle Libre devices for informed treatment decisions and remote patient monitoring.
Free
Merlin.net
Abbott (formerly St. Jude Medical)
Cardiology AI
Abbott's Merlin.net Patient Care Network (PCN) is a web-based remote monitoring platform for clinicians to manage data from patients with implanted cardiac devices, enabling remote follow-up, device performance monitoring, and informed clinical decisions.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-06-23 | First Added: 2026-06-23
AI Tool Finder
AI-powered search. Results may not be comprehensive.